Your browser doesn't support javascript.
loading
Clinical and Radiographic Predictors of Progression and Survival in Relapsed/Refractory Lymphoma Patients Receiving Anti-CD19 CAR T-cell Therapy.
Jodon, Gray; Colton, Meryl D; Abbott, Diana; Cai, Anthony; Haverkos, Bradley; Morgan, Rustain; Kamdar, Manali.
Affiliation
  • Jodon G; Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado Cancer Center, Aurora, CO. Electronic address: gray.jodon@cuanschutz.edu.
  • Colton MD; Department of Internal Medicine, University of Colorado School of Medicine, Aurora, CO.
  • Abbott D; Center for Innovative Design and Analysis, Department of Biostatistics and Informatics, University of Colorado School of Public Health, CO.
  • Cai A; Department of Radiology, University of Colorado School of Medicine, Aurora, CO.
  • Haverkos B; Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado Cancer Center, Aurora, CO.
  • Morgan R; Department of Radiology, University of Colorado School of Medicine, Aurora, CO.
  • Kamdar M; Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado Cancer Center, Aurora, CO.
Clin Lymphoma Myeloma Leuk ; 23(1): 49-56, 2023 01.
Article in En | MEDLINE | ID: mdl-36335021

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell / Lymphoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Lymphoma Myeloma Leuk Journal subject: NEOPLASIAS Year: 2023 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell / Lymphoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Lymphoma Myeloma Leuk Journal subject: NEOPLASIAS Year: 2023 Document type: Article Country of publication: United States